Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health.
about
The Potential Dangers of Using MDMA for PsychotherapyReasons for not using ecstasy: a qualitative study of non-users, ex-light users and ex-moderate users.Careers in ecstasy use: do ecstasy users cease of their own accord? Implications for intervention development.A structured review of reasons for ecstasy use and related behaviours: pointers for future research.Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study.Decision-making in chronic ecstasy users: a systematic review.The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.Party drugs: properties, prevalence, patterns, and problems.MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.Maximising the highs and minimising the lows: harm reduction guidance within ecstasy distribution networks.Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related ConditionsAn examination of sociodemographic correlates of ecstasy use among high school seniors in the United States.Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.Association of study characteristics with estimates of effect size in studies of ecstasy use.MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans - no need for translation.Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation.A longitudinal study of self-reported psychopathology in early ecstasy and amphetamine users.Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.Ecstasy cannot be assumed to be 3,4-methylenedioxyamphetamine (MDMA).Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling?Supply always comes on the heels of demand: what effects do control strategies have on drug users themselves?Desistance motivations among adolescent inhalant users: Latent class and latent profile analyses
P2860
Q21558619-7E90CB69-6A2E-4B01-9F30-E6CFEC24652CQ30416744-392FDBF2-8ED2-4F23-BF51-1C1F676452B4Q33379962-CB6E986F-663A-4C3E-962C-71F1A9249B34Q33481298-B3C5EE47-F3C1-4D6B-AF5C-2BB4F38FA8A5Q34359604-7637C1D3-CDC1-4745-B6B6-0C610455CA68Q34495787-5E87D3EB-AFBC-45B1-A092-37358AFF9A82Q34524956-8370C0AC-F1E9-4848-8C46-A66423D9EBD6Q34544993-FE2F1F27-D0FB-4F85-BA2B-96C034B8F7A2Q34565294-65BCA8AE-2B6A-4C76-8D2B-4505BD948CA1Q36020276-2FFFF4EC-7021-434D-9490-799C1BF16E8CQ36209983-3D07B424-7F2D-402C-949F-4E656F6A0973Q36410784-3564FC8E-E8CF-4981-943D-0F1E82F43152Q37021831-E346F587-6753-441B-BD0E-92E12F01269EQ37166739-A3489984-46F0-4865-8D58-81AAB00D678AQ37340869-7D5A9106-1221-4145-8B3E-A0D10E0C1776Q37416916-52C6C76B-C817-451F-B9A1-82385A8CADF8Q37936690-D8201A15-19A3-4FA0-84FA-36B23787928AQ37992113-53E7C392-8C30-4263-AA37-F3331E3B7C92Q38555614-6590FD64-DF43-4E54-9E4D-DA3E93E4D9D4Q45099576-F4034CA4-B949-49C0-8BAB-4B86EB36A645Q46477520-1B8B37B6-AA75-4CED-BD95-B1D93309C809Q46651207-36AA8AFE-D2D0-4170-8F96-1E78AAE3D3B0Q48375763-952F91FB-8815-4DF7-A2D3-456B8FB645ACQ52301576-D62A2E91-2167-470D-A70B-08C6BCA07634Q58245715-7C41AC8E-6023-44FB-8EEF-5C4BD00E5B56
P2860
Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Quitting ecstasy: an investiga ...... heir subsequent mental health.
@ast
Quitting ecstasy: an investiga ...... heir subsequent mental health.
@en
Quitting ecstasy: an investiga ...... heir subsequent mental health.
@nl
type
label
Quitting ecstasy: an investiga ...... heir subsequent mental health.
@ast
Quitting ecstasy: an investiga ...... heir subsequent mental health.
@en
Quitting ecstasy: an investiga ...... heir subsequent mental health.
@nl
prefLabel
Quitting ecstasy: an investiga ...... heir subsequent mental health.
@ast
Quitting ecstasy: an investiga ...... heir subsequent mental health.
@en
Quitting ecstasy: an investiga ...... heir subsequent mental health.
@nl
P2093
P2860
P356
P1476
Quitting ecstasy: an investiga ...... heir subsequent mental health.
@en
P2093
H Valerie Curran
Rachel Maidment
Suzanne L Verheyden
P2860
P304
P356
10.1177/0269881103174014
P407
P577
2003-12-01T00:00:00Z